Skip to main content

Table 1 Baseline clinical features of the participants according to serum uric acid level in men

From: The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study

 

SUA levels (μmol/L)

P value

<280

280 ~ 320

320 ~ 370

370 ~ 420

>420

(n = 1748)

(n = 1376)

(n = 1886)

(n = 1452)

(n = 1788)

Q1

Q2

Q3

Q4

Q5

Age(years)

66.4(11.09)

65.6(10.80)

65.8(11.19)

65.8(11.17)

66.2(11.48)

0.221

Age ≥ 65 (%)

955(54.6 %)

735(53.4 %)

1004(53.2 %)

774(53.3 %)

964(53.9 %)

0.918

Current smoker (%)

405(23.2 %)

305(22.2 %)

436(23.1 %)

307(21.1 %)

386(21.6 %)

0.015

Alcohol consumption (%)

304(17.4 %)

229(16.6 %)

302(16.0 %)

252(17.4 %)

310(17.3 %)

0.485

Sedentary lifestyle (%)

392(22.4 %)

293(21.3 %)

427(22.6 %)

358(24.7 %)

436(24.4 %)

0.145

Family history of premature CVD (%)

151(8.6 %)

114(8.3 %)

153(8.1 %)

133(9.2 %)

179(10.0 %)

0.282

Height (cm)

169.6(5.73)

170.0(5.54)

170.2(5.78)

169.9(5.52)

169.8(5.83)

0.009

Weight (kg)

70.23(10.30)

70.91(10.06)

71.78(10.10)

72.07(9.94)

72.96(10.85)

<0.001

BMI (kg/m2)

24.39(3.11)

24.50(3.00)

24.74(3.04)

24.93(2.96)

25.28(3.33)

<0.001

WC (cm)

88.65(11.08)

89.16(10.63)

89.75(11.36)

90.44(10.57)

91.09(11.15)

<0.001

SBP (mmHg)

130.3(15.25)

129.3(15.41)

130.2(14.67)

130.8(16.16)

131.4(15.71)

0.004

DBP (mmHg)

77.5(9.68)

77.6(9.47)

78.1(9.67)

78.1(9.99)

78.4(10.18)

0.049

FPG (mmol/L)a

6.82(2.88)

6.34 (2.27)

6.29(2.28)

6.34(2.35)

6.22(2.11)

<0.001

TC (mmol/L)

4.25(1.13)

4.23 (1.14)

4.22(1.12)

4.27(1.14)

4.28(1.14)

0.577

LDL-C (mmol/L)

2.44 (0.88)

2.43 (0.91)

2.44 (0.94)

2.43 (0.91)

2.42(0.91)

0.924

HDL-C (mmol/L)

1.23(0.35)

1.22 (0.35)

1.17 (0.31)

1.17(0.30)

1.12(0.31)

<0.001

TG (mmol/L)

1.52 (1.21)

1.65(1.32)

1.71 (1.36)

1.87(1.50)

2.18 (1.88)

<0.001

NonHDL-C (mmol/L)

3.01 (1.08)

3.01 (1.09)

3.05(1.07)

3.10(1.09)

3.16(1.08)

0.001

Diabetes mellitus (%)

819(46.9 %)

529(38.4 %)

679(36.0 %)

501(34.5 %)

592(33.1 %)

<0.001

Hypertension (%)

1100(62.9 %)

867(63.0 %)

1286(68.2 %)

1025(70.6 %)

1319(73.8 %)

<0.001

CHD (%)

705(40.3 %)

594(43.2 %)

826(43.8 %)

663(45.7 %)

849(47.5 %)

<0.001

Cerebrovascular disease (%)

384(22.0 %)

256(18.6 %)

379(20.1 %)

284(19.6 %)

335(18.7 %)

0.099

HF (%)

63(3.6 %)

44(3.2 %)

87(4.6 %)

60(4.1 %)

107(6.0 %)

0.001

Peripheral arterial disease (%)

31(1.8 %)

17(1.2 %)

20(1.1 %)

24(1.7 %)

25(1.4 %)

0.378

Antihypertention agents (%)

1012(57.9 %)

827(60.1 %)

1209(64.1 %)

960(66.1 %)

1255(70.2 %)

<0.001

Diuretic agents (%)

52(3.0 %)

33(2.4 %)

77(4.1 %)

76(5.2 %)

139(7.8 %)

<0.001

Antiplatelet agents (%)

1241(71.0 %)

981(71.3 %)

1370(72.6 %)

1057(72.8 %)

1293(72.3 %)

0.710

  1. aAmong 8250 men, 5211 subjects were documented the FBG. (1107 for Q1, 873 for Q2, 1205 for Q3, 907 for Q4, 1119 for Q5)
  2. Abbreviations: SUA serum uric acid, CVD cardiovascular disease, WC waist circumference, CHD coronary artery disease, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglyceride, TC total cholesterol, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, FPG fasting plasma glucose, HF heart failure, BMI body mass index